EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Historical Holders from Q3 2019 to Q2 2025

Symbol
XGN on Nasdaq
CUSIP
30068X103
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
9.11M
Holdings value
$63.6M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
52
Number of buys
36
Number of sells
-13
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NMSIC Co-Investment Fund, L.P. 9.83% -17.8% $7.18M -$1.43M 1.76M -16.6% NMSIC Co-Investment Fund, L.P. Mar 25, 2025
RTW INVESTMENTS, LP 7.7% $16.7M 1.7M RTW Investments, LP Jun 30, 2025
Cowen Financial Products LLC 5% $3.64M 891K Cowen Financial Products LLC Mar 31, 2025
LYTTON LAURENCE W 1% $2.14M 217K LYTTON LAURENCE W Jun 30, 2025

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 9.11M $63.6M +$21.4M $6.98 52
2025 Q1 6.24M $22.4M +$385K $3.59 38
2024 Q4 6.11M $25.1M -$538K $4.10 40
2024 Q3 6.39M $19.8M +$369K $3.09 33
2024 Q2 6.29M $11.4M +$147K $1.82 32
2024 Q1 6.2M $9.87M -$616K $1.59 30
2023 Q4 6.59M $13.1M -$546K $1.99 30
2023 Q3 6.87M $16.7M -$40.2K $2.42 29
2023 Q2 6.88M $20M +$147K $2.90 28
2023 Q1 6.83M $16.6M -$190K $2.43 27
2022 Q4 6.87M $16.5M -$1.42M $2.40 27
2022 Q3 7.79M $21.1M -$507K $2.71 32
2022 Q2 7.54M $43.3M -$6.49M $5.74 41
2022 Q1 8.56M $68.7M +$3.48M $8.03 52
2021 Q4 8.6M $100M -$2.77M $11.63 51
2021 Q3 8.65M $118M -$9.47M $13.60 52
2021 Q2 8.25M $124M -$16.8M $14.99 53
2021 Q1 8.53M $149M +$74.5M $17.50 55
2020 Q4 4.22M $55.6M +$2.49M $13.20 33
2020 Q3 4.28M $47M +$8.1M $10.84 32
2020 Q2 3.61M $44.7M -$5.87M $12.40 32
2020 Q1 3.87M $61.8M -$14M $15.94 32
2019 Q4 3.85M $97.7M +$14.4M $25.40 36
2019 Q3 3.58M $55.5M +$55.5M $15.49 27